Eli Lilly (LLY)
(Delayed Data from NYSE)
$745.69 USD
+14.36 (1.96%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $747.00 +1.31 (0.18%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Price, Consensus and EPS Surprise
LLY 745.69 +14.36(1.96%)
Will LLY be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for LLY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LLY
Eli Lilly (LLY) Reports Next Week: Wall Street Expects Earnings Growth
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
LLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
Company News for Apr 18, 2024
Eli Lilly's (LLY) Tirzepatide Meets Goals in Sleep Apnea Studies
Other News for LLY
3 Potential Biopharma Buyout Targets
REITs Q1 Earnings Begin On Solid Note
Market Whales and Their Recent Bets on LLY Options
TikTok to restrict weight loss drug promotion
Baron Health Care Fund Q1 2024 Shareholder Letter